
Sabiha Naim Qazi
Examiner (ID: 9471, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1629, 1611, 1621, 1612, 1202, 1616, 1628, 1627 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7784697
[patent_doc_number] => 20120046253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY'
[patent_app_type] => utility
[patent_app_number] => 13/283071
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3778
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046253.pdf
[firstpage_image] =>[orig_patent_app_number] => 13283071
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/283071 | STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY | Oct 26, 2011 | Abandoned |
Array
(
[id] => 9958015
[patent_doc_number] => 09006220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => '23-yne-vitamin D3 derivative'
[patent_app_type] => utility
[patent_app_number] => 13/880637
[patent_app_country] => US
[patent_app_date] => 2011-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14924
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880637
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/880637 | 23-yne-vitamin D3 derivative | Oct 23, 2011 | Issued |
Array
(
[id] => 8253086
[patent_doc_number] => 20120157418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => '2-Methylene-19-Nor-Vitamin D Analogs and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 13/278846
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15382
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157418.pdf
[firstpage_image] =>[orig_patent_app_number] => 13278846
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/278846 | 2-methylene-19-nor-vitamin D analogs and their uses | Oct 20, 2011 | Issued |
Array
(
[id] => 9122138
[patent_doc_number] => 20130289060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => '6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 13/879908
[patent_app_country] => US
[patent_app_date] => 2011-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12955
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879908
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879908 | 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN | Oct 18, 2011 | Abandoned |
Array
(
[id] => 7756786
[patent_doc_number] => 20120028934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D-CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY'
[patent_app_type] => utility
[patent_app_number] => 13/271890
[patent_app_country] => US
[patent_app_date] => 2011-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3779
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028934.pdf
[firstpage_image] =>[orig_patent_app_number] => 13271890
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/271890 | STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D-CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY | Oct 11, 2011 | Abandoned |
Array
(
[id] => 8096285
[patent_doc_number] => 20120083614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => '(20R,25S)-2-Methylene-19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 in Crystalline Form'
[patent_app_type] => utility
[patent_app_number] => 13/247600
[patent_app_country] => US
[patent_app_date] => 2011-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 48807
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083614.pdf
[firstpage_image] =>[orig_patent_app_number] => 13247600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/247600 | (20R,25S)-2-Methylene-19,26-Dinor-1α,25-Dihydroxyvitamin D3 in crystalline form | Sep 27, 2011 | Issued |
Array
(
[id] => 8359678
[patent_doc_number] => 20120214836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'SENSITIZER, PHARMACEUTICAL COMPOSITION, KIT AND USE FOR TARGET THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/238649
[patent_app_country] => US
[patent_app_date] => 2011-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4718
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13238649
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/238649 | SENSITIZER, PHARMACEUTICAL COMPOSITION, KIT AND USE FOR TARGET THERAPY | Sep 20, 2011 | Abandoned |
Array
(
[id] => 7711970
[patent_doc_number] => 20120004229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'SUBSTITUTED DIKETOPIPERAZINES AND THEIR USE AS OXYTOCIN ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/231211
[patent_app_country] => US
[patent_app_date] => 2011-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4459
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13231211
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/231211 | Substituted diketopiperazines and their use as oxytocin antagonists | Sep 12, 2011 | Issued |
Array
(
[id] => 8904875
[patent_doc_number] => 20130172378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Combination of BRAF and VEGF Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/820834
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15639
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/820834 | Combination of BRAF and VEGF Inhibitors | Sep 1, 2011 | Abandoned |
Array
(
[id] => 8905085
[patent_doc_number] => 20130172588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'CONTINUOUS PHOTOLYTIC PROCESS FOR THE PREPARATION OF VITAMIN D RELATED SUBSTANCES'
[patent_app_type] => utility
[patent_app_number] => 13/821686
[patent_app_country] => US
[patent_app_date] => 2011-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3767
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821686
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/821686 | CONTINUOUS PHOTOLYTIC PROCESS FOR THE PREPARATION OF VITAMIN D RELATED SUBSTANCES | Aug 31, 2011 | |
Array
(
[id] => 8211598
[patent_doc_number] => 20120129925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'SHIP 1 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/213901
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6902
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129925.pdf
[firstpage_image] =>[orig_patent_app_number] => 13213901
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/213901 | Ship 1 modulators | Aug 18, 2011 | Issued |
Array
(
[id] => 10169327
[patent_doc_number] => 09200029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Process for production of triterpene alcohol'
[patent_app_type] => utility
[patent_app_number] => 13/816778
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3345
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816778
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/816778 | Process for production of triterpene alcohol | Aug 18, 2011 | Issued |
Array
(
[id] => 10613783
[patent_doc_number] => 09333210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Medicine composition containing vitamin D and metformin'
[patent_app_type] => utility
[patent_app_number] => 13/980019
[patent_app_country] => US
[patent_app_date] => 2011-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 5759
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980019 | Medicine composition containing vitamin D and metformin | Aug 16, 2011 | Issued |
Array
(
[id] => 9148977
[patent_doc_number] => 20130303500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'COMPOUNDS AND METHODS FOR TREATING NEOPLASIA'
[patent_app_type] => utility
[patent_app_number] => 13/813398
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 36536
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813398
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813398 | COMPOUNDS AND METHODS FOR TREATING NEOPLASIA | Jul 28, 2011 | Abandoned |
Array
(
[id] => 11922631
[patent_doc_number] => 09790202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Anthranilamide derivatives as pesticides'
[patent_app_type] => utility
[patent_app_number] => 13/179217
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25600
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13179217
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/179217 | Anthranilamide derivatives as pesticides | Jul 7, 2011 | Issued |
Array
(
[id] => 7501611
[patent_doc_number] => 20110263552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'MODULATION OF SIDE EFFECT PROFILE OF 5-ALPHA REDUCTASE INHIBITOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/174756
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27446
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263552.pdf
[firstpage_image] =>[orig_patent_app_number] => 13174756
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/174756 | MODULATION OF SIDE EFFECT PROFILE OF 5-ALPHA REDUCTASE INHIBITOR THERAPY | Jun 29, 2011 | Abandoned |
Array
(
[id] => 9108372
[patent_doc_number] => 20130281504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Reduction of Microglia-Mediated Neurotoxicity by KCa3.1 Inhibition'
[patent_app_type] => utility
[patent_app_number] => 13/807245
[patent_app_country] => US
[patent_app_date] => 2011-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14454
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807245
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807245 | Reduction of Microglia-Mediated Neurotoxicity by KCa3.1 Inhibition | Jun 27, 2011 | Abandoned |
Array
(
[id] => 7670101
[patent_doc_number] => 20110319370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'Combination Hormone Therapy for the Eye'
[patent_app_type] => utility
[patent_app_number] => 13/169658
[patent_app_country] => US
[patent_app_date] => 2011-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3119
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169658
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/169658 | Combination Hormone Therapy for the Eye | Jun 26, 2011 | Abandoned |
Array
(
[id] => 7487158
[patent_doc_number] => 20110251065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'SOLID HERBICIDAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/164631
[patent_app_country] => US
[patent_app_date] => 2011-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3342
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251065.pdf
[firstpage_image] =>[orig_patent_app_number] => 13164631
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/164631 | SOLID HERBICIDAL COMPOSITION | Jun 19, 2011 | Abandoned |
Array
(
[id] => 7696055
[patent_doc_number] => 20110230535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'IMIDAZOLINYLMETHYL ARYL SULFONAMIDE'
[patent_app_type] => utility
[patent_app_number] => 13/152611
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8611
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230535.pdf
[firstpage_image] =>[orig_patent_app_number] => 13152611
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/152611 | IMIDAZOLINYLMETHYL ARYL SULFONAMIDE | Jun 2, 2011 | Abandoned |